Given their role in cancer progression and resistance to treatment, targeting CSCs offers a promising approach to improving cancer therapy. Strategies to target CSCs include inhibiting key signaling pathways like Wnt, Notch, and Hedgehog, which are essential for CSC maintenance. Additionally, combining CSC-targeted therapies with conventional treatments could potentially eliminate both CSCs and the bulk of the tumor.
